Literature DB >> 5276332

Respiratory syncytial virus neutralizing activity in nasopharyngeal secretions.

R Scott, P S Gardner.   

Abstract

Nasopharyngeal secretions were taken during the acute phase of illness from 30 children admitted to hospital with lower respiratory tract infections. The presence of neutralizing activity in secretions taken at the onset of illness was demonstrated in 11 out of 15 patients (73%) with bronchiolitis caused by R.S. virus, as compared with 4 out of 9 patients (44%) with R.S. virus infections other than bronchiolitis, and 1 out of 6 without R.S. virus infection. Second secretions were taken 7 days later from 10 of the children with R.S. virus infection. Eight of these paired secretions showed an increase of neutralizing activity against R.S. virus. It is suggested that the neutralizing activity, found in secretions taken at the onset of illness, may be a result of previous infection with R.S. virus.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5276332      PMCID: PMC2130856          DOI: 10.1017/s0022172400042510

Source DB:  PubMed          Journal:  J Hyg (Lond)        ISSN: 0022-1724


  18 in total

1.  QUANTITATIVE DETERMINATION OF SERUM IMMUNOGLOBULINS IN ANTIBODY-AGAR PLATES.

Authors:  J L FAHEY; E M MCKELVEY
Journal:  J Immunol       Date:  1965-01       Impact factor: 5.422

2.  Respiratory syncytial virus. I. Virus recovery and other observations during 1960 outbreak of bronchiolitis, pneumonia, and minor respiratory diseases in children.

Authors:  R M CHANOCK; H W KIM; A J VARGOSKO; A DELEVA; K M JOHNSON; C CUMMING; R H PARROTT
Journal:  JAMA       Date:  1961-05-27       Impact factor: 56.272

3.  THE INACTIVATION OF EPIDEMIC INFLUENZA VIRUS BY NASAL SECRETIONS OF HUMAN INDIVIDUALS.

Authors:  T Francis
Journal:  Science       Date:  1940-02-23       Impact factor: 47.728

4.  Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine.

Authors:  H W Kim; J G Canchola; C D Brandt; G Pyles; R M Chanock; K Jensen; R H Parrott
Journal:  Am J Epidemiol       Date:  1969-04       Impact factor: 4.897

5.  Field evaluation of a respiratory syncytial virus vaccine and a trivalent parainfluenza virus vaccine in a pediatric population.

Authors:  J Chin; R L Magoffin; L A Shearer; J H Schieble; E H Lennette
Journal:  Am J Epidemiol       Date:  1969-04       Impact factor: 4.897

6.  Protective effect of antibody to parainfluenza type 1 virus.

Authors:  C B Smith; R H Purcell; J A Bellanti; R M Chanock
Journal:  N Engl J Med       Date:  1966-11-24       Impact factor: 91.245

7.  Application of immunofluorescent antibody technique in rapid diagnosis of respiratory syncytial virus infection.

Authors:  P S Gardner; J McQuillin
Journal:  Br Med J       Date:  1968-08-10

8.  Respiratory syncytial virus neutralizing activity in nasal secretions following natural infection.

Authors:  H W Kim; J A Bellanti; J O Arrobio; J Mills; C D Brandt; R M Chanock; R H Parrott
Journal:  Proc Soc Exp Biol Med       Date:  1969-06

9.  Respiratory virus immunization. I. A field trial of two inactivated respiratory virus vaccines; an aqueous trivalent parainfluenza virus vaccine and an alum-precipitated respiratory syncytial virus vaccine.

Authors:  V A Fulginiti; J J Eller; O F Sieber; J W Joyner; M Minamitani; G Meiklejohn
Journal:  Am J Epidemiol       Date:  1969-04       Impact factor: 4.897

10.  The late detection of respiratory syncytial virus in cells of respiratory tract by immunofluorescence.

Authors:  P S Gardner; J McQuillin; R McGuckin
Journal:  J Hyg (Lond)       Date:  1970-12
View more
  9 in total

Review 1.  Respiratory syncytial virus. Brief review.

Authors:  E J Stott; G Taylor
Journal:  Arch Virol       Date:  1985       Impact factor: 2.574

2.  Cell-free and cell-bound antibody in nasal secretions from infants with respiratory syncytial virus infection.

Authors:  K McIntosh; J McQuillin; P S Gardner
Journal:  Infect Immun       Date:  1979-02       Impact factor: 3.441

3.  Breast-feeding protects against respiratory syncytial virus infections.

Authors:  M A Downham; R Scott; D G Sims; J K Webb; P S Gardner
Journal:  Br Med J       Date:  1976-07-31

4.  Class-specific antibodies to bovine respiratory syncytial virus in experimentally infected lambs.

Authors:  R Sharma; Z Woldehiwet
Journal:  Epidemiol Infect       Date:  1992-02       Impact factor: 2.451

5.  The local antibody response to R.S. virus infection in the respiratory tract.

Authors:  R Scott; P S Gardner
Journal:  J Hyg (Lond)       Date:  1974-02

6.  Ontogenesis of the formation of secretory antibodies to respiratory syncytial (RS) virus.

Authors:  N P Leschinskaya; E E Pokrovskaya; E A Kantorovitch; S K Grigorjeva
Journal:  Epidemiol Infect       Date:  1988-12       Impact factor: 2.451

7.  Comparison of immunofluorescence and isolation techniques in the diagnosis of respiratory viral infections of children.

Authors:  R E Fulton; P J Middleton
Journal:  Infect Immun       Date:  1974-07       Impact factor: 3.441

8.  The late detection of respiratory syncytial virus in cells of respiratory tract by immunofluorescence.

Authors:  P S Gardner; J McQuillin; R McGuckin
Journal:  J Hyg (Lond)       Date:  1970-12

9.  Nasal IgA response in wheezy infants.

Authors:  I M Balfour-Lynn; B Valman; M Silverman; A D Webster
Journal:  Arch Dis Child       Date:  1993-04       Impact factor: 3.791

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.